Company Name, Ticker, Competitors, else..

Adhera Therapeutics Inc (ATRX)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Adhera Therapeutics Inc 's

Name: Adhera Therapeutics Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ATRX Sales vs. its Competitors Q2 2023

Comparing the current results to its competitors, Adhera Therapeutics Inc reported Revenue decrease in the 2 quarter 2023 year on year by 0 %, despite the revenue increase by the most of its competitors of 3.78 %, recorded in the same quarter.

• List of ATRX Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Adhera Therapeutics Inc Net Income in the 2 quarter 2023 grew year on year by 173.74%, faster than the Adhera Therapeutics Inc 's competitors average income growth of 46.46 %

<< ATRX Stock Performance Comparisons

<< See the full list of ATRX competitors

*Market share is calculated based on total revenue.

ATRX's Stock Performance relative to its Competitors

Publicly Traded Peers of Adhera Therapeutics Inc

Eqrx Inc
Share Performance

+4.46%

This Quarter

Eqrx Inc

Profile

Eqrx Inc is a pharmaceutical company that focuses on creating affordable and accessible medication. They employ an innovative business model that combines research and development with scientific expertise to develop generic alternatives to the high-priced drugs in the market. By bypassing the traditional pharmaceutical pricing system, Eqrx aims to make essential medications more affordable for patients and healthcare providers.

More about Eqrx Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 1,133.098 mill.	$ - mill.	$ -259.623 mill.

Acelyrin Inc
Share Performance

+6.57%

This Quarter

Acelyrin Inc

Profile

Acelyrin Inc is a technology company that focuses on providing cutting-edge solutions in the healthcare industry. Their business model is centered around developing innovative software and hardware products that improve patient outcomes, enhance operational efficiency, and drive cost savings for healthcare organizations. By offering a range of advanced tools and services, Acelyrin Inc aims to revolutionize the healthcare sector and contribute to the overall advancement of digital health.

More about Acelyrin Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 228.544 mill.	$ - mill.	$ -268.517 mill.

Dianthus Therapeutics Inc
Share Performance

+172.40%

This Year

Dianthus Therapeutics Inc

Profile

Dianthus Therapeutics Inc is a biotechnology company that focuses on developing novel genetic medicines for patients suffering from rare genetic diseases. Their business model revolves around leveraging cutting-edge gene therapy technologies to design and deliver innovative treatments. By partnering with academic institutions and utilizing a proprietary gene therapy platform, they aim to address unmet medical needs and provide potential new therapies for patients with genetic disorders.

More about Dianthus Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 6,056.188 mill.	$ 1.441 mill.	$ -192.246 mill.

Medicure Inc
Share Performance

0.00%

Over The Past 5 Days

Medicure Inc

Profile

Medicure Inc operates as a pharmaceutical company with a business model that focuses on the research, development, and commercialization of innovative cardiovascular and other specialty pharmaceuticals. They aim to address unmet medical needs, improve patient outcomes, and deliver value to healthcare providers and consumers.

More about Medicure Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ - mill.	$ 25.925 mill.	$ -5.920 mill.

Nexien Biopharma Inc
Share Performance

0.00%

This Quarter

Nexien Biopharma Inc

Profile

Nexien Biopharma Inc operates as a biotechnology company focused on the development and commercialization of innovative therapies for various medical conditions. They aim to use their expertise in biopharmaceutical research to bring novel treatments to market, improving patient outcomes and meeting unmet medical needs.

More about Nexien Biopharma Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 0.007 mill.	$ - mill.	$ -0.188 mill.

104 more competitors available

Sources: Adhera Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 12, 2026 8:16 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Adhera Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.